Skip to main content
. 2021 Mar 15;22(6):2983. doi: 10.3390/ijms22062983
AdvSM Advanced systemic mastocytosis
BM Bone marrow
CR Complete remission/response
CRh Complete response with partial hematologic recovery
ECNM European Competence Network on Mastocytosis
EMA European Medicines Agency
FDA Food and Drug Administration
HαT Hereditary alpha-tryptasemia
ISM Indolent systemic mastocytosis
IWG-MRT-ECN International Working Group-Myeloproliferative Neoplasms Research and Treatment
MC Mast cells
MCL Mast cell leukemia
mIWG-MRT-ECNM Modified International Working Group-Myeloproliferative Neoplasms Research and Treatment
MR Major response
PPR Pure pathologic response
PR Partial response
SM Systemic mastocytosis
SM-AHN Systemic mastocytosis with an associated hematologic neoplasm
SSM Smoldering systemic mastocytosis
WHO World Health Organization